0001127602-24-013916.txt : 20240502
0001127602-24-013916.hdr.sgml : 20240502
20240502160555
ACCESSION NUMBER: 0001127602-24-013916
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240430
FILED AS OF DATE: 20240502
DATE AS OF CHANGE: 20240502
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DeLuca Richard R.
CENTRAL INDEX KEY: 0001421339
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-06571
FILM NUMBER: 24908142
MAIL ADDRESS:
STREET 1: 2000 GALLOPING HILL ROAD
CITY: KENILWORTH
STATE: NJ
ZIP: 07033
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Merck & Co., Inc.
CENTRAL INDEX KEY: 0000310158
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 221918501
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2000 GALLOPING HILL ROAD
CITY: KENILWORTH
STATE: NJ
ZIP: 07033
BUSINESS PHONE: 908-740-4000
MAIL ADDRESS:
STREET 1: 2000 GALLOPING HILL ROAD
CITY: KENILWORTH
STATE: NJ
ZIP: 07033
FORMER COMPANY:
FORMER CONFORMED NAME: Merck & Co. Inc.
DATE OF NAME CHANGE: 20091103
FORMER COMPANY:
FORMER CONFORMED NAME: SCHERING PLOUGH CORP
DATE OF NAME CHANGE: 19920703
4
1
form4.xml
PRIMARY DOCUMENT
X0508
4
2024-04-30
0000310158
Merck & Co., Inc.
MRK
0001421339
DeLuca Richard R.
MERCK & CO., INC.
126 EAST LINCOLN AVENUE
RAHWAY
NJ
07065
1
EVP&Pres, Merck Animal Heallth
0
Common Stock
136593.559
D
Common Stock - 401(k) Plan
1236.6018
I
By 401(k)
Restricted Stock Unit
2024-04-30
4
A
0
23216
0
A
2027-04-30
2027-04-30
Common Stock
23216
23216
D
Stock Option (Right to Buy)
129.22
2024-04-30
4
A
0
37500
0
A
2025-04-30
2034-04-29
Common Stock
37500
37500
D
Holdings include shares acquired in dividend reinvestment transactions.
Includes shares acquired and dividends earned through April 5, 2024 in the Merck U.S. Savings Plan, a 401(k) plan.
Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
These restricted stock units vest in full and are distributed as shares of Merck & Co., Inc. common stock on 04/30/2027.
The option vests and becomes exercisable in three equal installments on 4/30/2025, 4/30/2026 and 4/30/2027.
/s/ Kelly E. W. Grez as Attorney-in-Fact for Richard R. DeLuca, Jr.
2024-05-02